Connected health technology aids patients and health care professionals during COVID-19 crisis

Posted on April 15, 2020 — Jessica Jones Gupta

Connected health technology is rapidly expanding and responding to emerging needs during the coronavirus crisis.  Here is some information on health care partners and health care technology companies and what they are doing to assist patients and providers during the pandemic. This article features two Penn spinouts: Neuroflow and TrekIt Health Read More on the…

New scavenger technology allows robots to ‘eat’ metal for energy

Posted on April 14, 2020 — Jessica Jones Gupta

Rather than a battery, the researchers’ metal-air scavenger vehicle gets energy from breaking chemical bonds in the aluminum surface it travels over. The vehicle keeps going until the hydrogel slab it’s dragging dries out or the surface is completely corroded, but a freely moving robot could seek out new sources of water and metal. Read…

Two Pennovation startups in the Science Center’s first cohort of Launch Lane tech startup accelerator

Posted on April 9, 2020 — Jessica Jones Gupta

The seven tech startups chosen — based as close as Pennovation and as far away as Istanbul — will receive a collective $300,000 investment and access to various resources through February.  The two Pennovation startups are the OrVac and Tozuda. Read more on Philly

Pinpoint Therapeutics targets COVID-19 with new autophagy pathway

Posted on April 3, 2020 — Jessica Jones Gupta

Pinpoint Therapeutics believes that its approach to treat therapy-resistant cancers also may be effective against COVID-19. The molecule Pinpoint is developing, dimeric chloroquine, targets PPT1, an enzyme in the autophagy pathway that tumors use to block therapeutics. CEO Christian Peters, M.D., Ph.D., believes targeting this pathway and, specifically, the PPT1 enzyme, could prevent the COVID-19…

Latest Penn biotech spinout taking on cancer raises $1.6M from investors

Posted on April 2, 2020 — Jessica Jones Gupta

Another Philadelphia biopharmaceutical company spun out the University of Pennsylvania and targeting cancer has attracted a multimillion-dollar investment. Interius BioTherapeutics, founded by Dr. Saar Gill, raised $1.58 million from private investors in an equity financing. Read more on the Philadelphia Business Journal

First-of-its-kind engineered macrophage cell therapy platform shows ability to reduce tumor burden and activate anti-tumor immunity

Posted on — Jessica Jones Gupta

Study highlights previously untapped potential of genetically engineered macrophages in immunotherapy for solid tumors Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Nature Biotechnology has published a study from the Perelman School of Medicine at the University of Pennsylvania demonstrating Carisma’s foundational technology evaluating the potential of human chimeric antigen receptor…